• LAST PRICE
    21.7900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    17.5200/ 1
  • Ask / Lots
    26.3000/ 1
  • Open / Previous Close
    --- / 21.7900
  • Day Range
    ---
  • 52 Week Range
    Low 18.6200
    High 26.3400
  • Volume
    545
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 22.5
TimeVolumeSEPN
09:32 ET40923.095
09:33 ET431022.82
09:35 ET40022.7
09:37 ET40022.68
09:39 ET20023.225
09:44 ET20023.165
09:46 ET10023.09
09:55 ET10022.7723
10:09 ET10022.7
10:13 ET10022.68
10:15 ET20022.68
10:20 ET50023.06
10:24 ET71622.71
10:26 ET30022.705
10:33 ET32922.635
10:36 ET10022.62
10:38 ET10022.62
10:40 ET20022.61
10:44 ET40022.88
10:45 ET174323.12
10:47 ET47623
10:49 ET50022.96
10:54 ET10022.985
10:56 ET10023.035
11:02 ET10023.05
11:03 ET40023
11:07 ET20022.995
11:12 ET10023
11:14 ET55523
11:16 ET10023
11:23 ET31223
11:27 ET20022.965
11:36 ET13022.925
11:38 ET10022.71
11:39 ET30022.705
11:50 ET10022.605
11:52 ET30022.51
12:10 ET10022.505
12:19 ET14022.485
12:26 ET10022.485
12:32 ET10022.47
12:42 ET322022.66
12:44 ET10022.66
12:46 ET170022.78
12:48 ET256122.86
12:50 ET20022.945
12:51 ET346822.885
12:53 ET30022.49
12:57 ET10022.45
01:00 ET80022.1
01:02 ET10022.08
01:04 ET20021.96
01:06 ET20022.115
01:08 ET325121.77
01:09 ET10021.97
01:13 ET20021.97
01:15 ET10022.21
01:18 ET20021.97
01:22 ET20021.97
01:24 ET20021.97
01:26 ET70021.975
01:31 ET100022.22
01:33 ET50022.44
01:36 ET50622.22
01:38 ET10022.43
01:40 ET60022.29
01:44 ET10022.5
01:45 ET30022.405
01:49 ET20022.405
01:51 ET10022.345
01:56 ET40022.32
01:58 ET10022.32
02:09 ET233822.49
02:12 ET40022.545
02:14 ET10022.54
02:16 ET10022.545
02:20 ET10022.545
02:21 ET889222.49
02:25 ET100022.605
02:27 ET343022.74
02:30 ET10022.84
02:32 ET40022.84
02:34 ET10022.78
02:36 ET30022.715
02:38 ET20022.59
02:41 ET20022.63
02:45 ET33022.51
02:48 ET10022.53
02:50 ET10022.455
02:52 ET35022.32
02:54 ET10022.33
02:56 ET44522.35
02:59 ET10022.33
03:01 ET10022.49
03:03 ET30022.39
03:06 ET160022.39
03:08 ET20022.39
03:10 ET368822.345
03:12 ET10022.325
03:14 ET10022.32
03:15 ET40022.26
03:17 ET20022.08
03:19 ET90022.04
03:21 ET260021.9
03:24 ET30021.91
03:26 ET10022.03
03:28 ET20022.03
03:30 ET40021.87
03:32 ET71622.035
03:33 ET30022.03
03:35 ET40022.025
03:37 ET20021.975
03:39 ET75021.935
03:42 ET30021.84
03:44 ET31421.945
03:46 ET171421.89
03:48 ET368821.79
03:50 ET450822.11
03:51 ET360022.16
03:53 ET215022.08
03:55 ET519621.74
03:57 ET305321.825
04:00 ET2129721.79
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSEPN
Septerna Inc
915.2M
-87,160.0x
---
United StatesNUVB
Nuvation Bio Inc
908.7M
-1.2x
---
United StatesAVBP
Arrivent Biopharma Inc
893.0M
-10.1x
---
United StatesLENZ
LENZ Therapeutics Inc
943.8M
-4.8x
---
United StatesBCAX
Bicara Therapeutics Inc
870.1M
0.0x
---
United StatesUPB
Upstream Bio Inc
954.0M
0.0x
---
As of 2024-11-22

Company Information

Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. It is focused in major therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Contact Information

Headquarters
250 East Grand Avenue, Suite 65SOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-338-3533
Fax
302-655-5049

Executives

Chairman of the Board
Jeffrey Tong
President, Chief Executive Officer, Director
Jeffrey Finer
Chief Operating Officer
Elizabeth Bhatt
Chief People Officer
Samira Shaikhly
Senior Vice President - Biological Sciences
Uwe Klein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$915.2M
Revenue (TTM)
$840.00
Shares Outstanding
42.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
-87,160.0x
Price/Sales (TTM)
1,089,573.0
Price/Cash Flow (TTM)
---
Operating Margin
-1,342.86%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.